Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19

BACKGROUND: Lianhua Qingwen Capsules (LHQW) is a traditional Chinese medicine prescription commonly used to treat viral influenza in China. There has been sufficient evidence that LHQW could effectively treat COVID-19. Nevertheless, the potential anti-(mutant) SARS-CoV-2 and anti-inflammation compou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Liang, He, Min, Li, Shaoping, Zhao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261255/
https://www.ncbi.nlm.nih.gov/pubmed/35799189
http://dx.doi.org/10.1186/s13020-022-00637-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261255/
https://www.ncbi.nlm.nih.gov/pubmed/35799189
http://dx.doi.org/10.1186/s13020-022-00637-0

Ejemplares similares